Send Us Your Questions

At ProMIS Neurosciences, we’re using our proprietary computational modeling platform to generate monoclonal antibodies that selectively target conformational epitopes on the surface of toxic oligomers of proteins implicated in the development of neurodegenerative diseases, including Alzheimer’s, amyotrophic lateral sclerosis (ALS), and Parkinson’s.

If you would like to learn more about our science and programs, please reach out to us using the information provided.

Toronto, Canada Office


1920 Yonge Street
Suite 200
Toronto, ON M4S 3E2

Cambridge, MA U.S. Office


Cambridge Innovation Center
1 Broadway
Cambridge, MA 02142

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

*Required fields